Cargando…
Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing
BACKGROUND: Higher mortality of COVID-19 patients with lung disease is a formidable challenge for the health care system. Genetic association between COVID-19 and various lung disorders must be understood to comprehend the molecular basis of comorbidity and accelerate drug development. METHODS: Lung...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447809/ https://www.ncbi.nlm.nih.gov/pubmed/34535131 http://dx.doi.org/10.1186/s12920-021-01079-7 |